These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

879 related items for PubMed ID: 9033462

  • 1. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group.
    Lancet; 1997 Feb 08; 349(9049):375-80. PubMed ID: 9033462
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study.
    Olsen SL, Gilbert EM, Renlund DG, Taylor DO, Yanowitz FD, Bristow MR.
    J Am Coll Cardiol; 1995 May 08; 25(6):1225-31. PubMed ID: 7722114
    [Abstract] [Full Text] [Related]

  • 4. Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
    Doughty RN, Whalley GA, Gamble G, MacMahon S, Sharpe N.
    J Am Coll Cardiol; 1997 Apr 08; 29(5):1060-6. PubMed ID: 9120160
    [Abstract] [Full Text] [Related]

  • 5. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial.
    Hori M, Sasayama S, Kitabatake A, Toyo-oka T, Handa S, Yokoyama M, Matsuzaki M, Takeshita A, Origasa H, Matsui K, Hosoda S, MUCHA Investigators.
    Am Heart J; 2004 Feb 08; 147(2):324-30. PubMed ID: 14760332
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Tolerability and efficacy of carvedilol in patients with New York Heart Association class IV heart failure.
    Macdonald PS, Keogh AM, Aboyoun CL, Lund M, Amor R, McCaffrey DJ.
    J Am Coll Cardiol; 1999 Mar 15; 33(4):924-31. PubMed ID: 10091817
    [Abstract] [Full Text] [Related]

  • 8. Effects of carvedilol on left ventricular regional wall motion in patients with heart failure caused by ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
    Doughty RN, Whalley GA, Gamble G, MacMahon S, Sharpe N.
    J Card Fail; 2000 Mar 15; 6(1):11-8. PubMed ID: 10746814
    [Abstract] [Full Text] [Related]

  • 9. Effects of carvedilol on ventriculo-arterial coupling in patients with heart failure.
    Razzolini R, Tarantini G, Boffa GM, Orlando S, Iliceto S.
    Ital Heart J; 2004 Jul 15; 5(7):517-22. PubMed ID: 15487269
    [Abstract] [Full Text] [Related]

  • 10. Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy.
    Quaife RA, Gilbert EM, Christian PE, Datz FL, Mealey PC, Volkman K, Olsen SL, Bristow MR.
    Am J Cardiol; 1996 Oct 01; 78(7):779-84. PubMed ID: 8857482
    [Abstract] [Full Text] [Related]

  • 11. [The effects of mid- and long-term administration (3-4 years) of carvedilol in patients with idiopathic dilated cardiomyopathy].
    Metra M, Nodari S, Garbellini M, Boldi E, Rosselli F, Milan E, Giubbini R, Dei Cas L.
    Cardiologia; 1997 May 01; 42(5):503-12. PubMed ID: 9289367
    [Abstract] [Full Text] [Related]

  • 12. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
    Sliwa K, Norton GR, Kone N, Candy G, Kachope J, Woodiwiss AJ, Libhaber C, Sareli P, Essop R.
    J Am Coll Cardiol; 2004 Nov 02; 44(9):1825-30. PubMed ID: 15519014
    [Abstract] [Full Text] [Related]

  • 13. Landmark studies: the Australia/New Zealand Heart Failure Collaborative Group (ANZ) Trial and the US Carvedilol Trials Program.
    Gilbert EM.
    Am J Cardiol; 2004 May 06; 93(9A):30B-4B. PubMed ID: 15144934
    [Abstract] [Full Text] [Related]

  • 14. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A, Macdonald PS, Keogh AM, Kotlyar E, Mellemkjaer S, Coleman CF, Elsik M, Krum H, Hayward CS.
    J Am Coll Cardiol; 2010 Apr 27; 55(17):1780-7. PubMed ID: 20413026
    [Abstract] [Full Text] [Related]

  • 15. The effect of carvedilol on B-type natriuretic peptide and cardiac function in patients with heart failure and persistent atrial fibrillation.
    Khand AU, Chew PG, Douglas H, Jones J, Jan A, Cleland JG.
    Cardiology; 2015 Apr 27; 130(3):153-8. PubMed ID: 25660493
    [Abstract] [Full Text] [Related]

  • 16. Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol.
    Capomolla S, Febo O, Gnemmi M, Riccardi G, Opasich C, Caporotondi A, Mortara A, Pinna GD, Cobelli F.
    Am Heart J; 2000 Apr 27; 139(4):596-608. PubMed ID: 10740140
    [Abstract] [Full Text] [Related]

  • 17. Effects of nebivolol versus carvedilol on left ventricular function in patients with chronic heart failure and reduced left ventricular systolic function.
    Lombardo RM, Reina C, Abrignani MG, Rizzo PA, Braschi A, De Castro S.
    Am J Cardiovasc Drugs; 2006 Apr 27; 6(4):259-63. PubMed ID: 16913827
    [Abstract] [Full Text] [Related]

  • 18. Betaxolol is equivalent to carvedilol in patients with heart failure NYHA II or III: result of a randomized multicenter trial (BETACAR Trial).
    Figulla HR, Krzeminska-Pakula M, Wrabec K, Chochola J, Kalmbach C, Fridl P.
    Int J Cardiol; 2006 Nov 10; 113(2):153-60. PubMed ID: 16157399
    [Abstract] [Full Text] [Related]

  • 19. Effect of carvedilol on survival in severe chronic heart failure.
    Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Roecker EB, Schultz MK, DeMets DL, Carvedilol Prospective Randomized Cumulative Survival Study Group.
    N Engl J Med; 2001 May 31; 344(22):1651-8. PubMed ID: 11386263
    [Abstract] [Full Text] [Related]

  • 20. Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study Group.
    Cohn JN, Fowler MB, Bristow MR, Colucci WS, Gilbert EM, Kinhal V, Krueger SK, Lejemtel T, Narahara KA, Packer M, Young ST, Holcslaw TL, Lukas MA.
    J Card Fail; 1997 Sep 31; 3(3):173-9. PubMed ID: 9330125
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.